Literature DB >> 1833404

Functional dissection in vitro of the human c-fos promoter.

R A Hipskind1, A Nordheim.   

Abstract

Using internal and 5' deletions, the elements contributing to the in vitro activity of the human c-fos promoter have been identified. Wild type and mutant promoters were fused to the G-free cassette and tested, using HeLa nuclear and whole cell extracts, with the fos wild type promoter as the internal control. The proximal promoter domain, spanning from -124 to -58 in the fos promoter, is the primary determinant of activity. Two elements in this domain are important, the direct repeats and the -60 element, which contains overlapping MLTF/USF and CREB/ATF transcription factor binding sites. CREB/ATF appears to be dominant, since a canonical CRE functions well in place of the -60 element. Interestingly, the direct repeats appear to require the -60 element to exert their effect. Upstream elements do not Influence promoter activity in their normal position or adjacent to the TATA box, except the serum response element (SRE). Templates containing various lengths of the fos wild type SRE next to the TATA box are stimulated by adding purified serum response factor (SRF), while SRE mutants are not responsive. The stimulation is independent of small spacing differences between the SRE and TATA elements, and the CArG core of the fos SRE suffices to respond to added SRF in vitro.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1833404

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  12 in total

1.  Shear stress induction of the tissue factor gene.

Authors:  M C Lin; F Almus-Jacobs; H H Chen; G C Parry; N Mackman; J Y Shyy; S Chien
Journal:  J Clin Invest       Date:  1997-02-15       Impact factor: 14.808

2.  TAFII250-dependent transcription of cyclin A is directed by ATF activator proteins.

Authors:  E H Wang; S Zou; R Tjian
Journal:  Genes Dev       Date:  1997-10-15       Impact factor: 11.361

3.  Receptor-Ck-dependent regulation of genes involved in the cell cycle.

Authors:  M Kaur; D Kaul; R C Sobti
Journal:  Mol Cell Biochem       Date:  1998-04       Impact factor: 3.396

4.  The small GTP-binding protein Rho links G protein-coupled receptors and Galpha12 to the serum response element and to cellular transformation.

Authors:  C Fromm; O A Coso; S Montaner; N Xu; J S Gutkind
Journal:  Proc Natl Acad Sci U S A       Date:  1997-09-16       Impact factor: 11.205

5.  Spontaneous and cytokine regulated c-fos gene expression in rheumatoid synovial cells: resistance to cytokine stimulation when the c-fos gene is overexpressed.

Authors:  K Shimizu; H Kawasaki; T Morisawa; M Nakamura; E Yamamoto; N Yoshikawa; M Doita; K Shiozawa; S Yonehara; K Chihara; S Shiozawa
Journal:  Ann Rheum Dis       Date:  2000-08       Impact factor: 19.103

6.  Identification of the cyclin D1 gene as a target of activating transcription factor 2 in chondrocytes.

Authors:  F Beier; R J Lee; A C Taylor; R G Pestell; P LuValle
Journal:  Proc Natl Acad Sci U S A       Date:  1999-02-16       Impact factor: 11.205

7.  Dissection of the functional architecture of a plant defense gene promoter using a homologous in vitro transcription initiation system.

Authors:  J A Arias; R A Dixon; C J Lamb
Journal:  Plant Cell       Date:  1993-04       Impact factor: 11.277

8.  Rsk-2 activity is necessary for epidermal growth factor-induced phosphorylation of CREB protein and transcription of c-fos gene.

Authors:  D De Cesare; S Jacquot; A Hanauer; P Sassone-Corsi
Journal:  Proc Natl Acad Sci U S A       Date:  1998-10-13       Impact factor: 11.205

9.  Streptolysin O-permeabilized cell system for studying trans-acting activities of exogenous nuclear proteins.

Authors:  S H Liu; J C Chu; S Y Ng
Journal:  Nucleic Acids Res       Date:  1993-08-25       Impact factor: 16.971

10.  Identification of a novel E1A response element in the mouse c-fos promoter.

Authors:  R W Gedrich; D A Engel
Journal:  J Virol       Date:  1995-04       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.